Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

NSE:NIDAN Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	10.4	19.95	18.99	28.5	84.19	81.01
Cash & Short-Term Investments	10.4	19.95	18.99	28.5	84.19	81.01
Cash Growth	-42.17%	5.01%	-33.35%	-66.15%	3.92%	9.53%
Accounts Receivable	20.87	22.17	12.68	5.24	60.26	53.62
Other Receivables	-	6.18	6.77	7.59	12.31	14.19
Receivables	98.11	91.97	62.68	252.28	100.89	153.26
Inventory	5.15	5.3	5.47	3.02	3.65	2.16
Prepaid Expenses	-	0.55	1.15	0.19	0.48	0.35
Other Current Assets	36.29	27.85	23.73	18.79	19.59	16.25
Total Current Assets	149.94	145.62	112.02	302.78	208.81	253.03
Property, Plant & Equipment	145.91	133.96	148.19	163.18	197.15	242.62
Long-Term Investments	200	200	200	-	-	-
Other Intangible Assets	0.15	16.66	16.65	16.69	16.78	0.12
Long-Term Deferred Tax Assets	4.65	6.35	7.69	8.2	4.83	4.54
Other Long-Term Assets	7.45	48.55	48.01	48.93	94.01	384.49
Total Assets	863.09	839.95	829.41	825.51	844.02	884.79

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	6.67	7.74	9.63	7.3	2.06	11.49
Accrued Expenses	-	14.12	15.12	13.32	5.84	4.98
Short-Term Debt	-	72.07	69.36	73.66	48.89	87.09
Current Portion of Long-Term Debt	91.05	3.22	2.8	7.75	12.66	11.68
Current Income Taxes Payable	-	5.02	5.06	11.17	26.23	12.59
Other Current Liabilities	21.73	-0	-	-	-	-
Total Current Liabilities	119.46	102.16	101.96	113.2	95.69	127.83
Long-Term Debt	31.43	36.35	38.95	42.94	47.75	94.17
Pension & Post-Retirement Benefits	-	3.91	5.93	5.65	4.52	0.39
Other Long-Term Liabilities	4.39	0.64	0.74	1.66	1.67	3.4
Total Liabilities	155.27	143.06	147.58	163.45	149.63	225.8

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	139	139	139	139	139	139
Additional Paid-In Capital	-	459.05	459.05	459.05	459.05	459.05
Retained Earnings	-	98.84	83.78	64.01	96.33	60.94
Shareholders' Equity	707.82	696.89	681.83	662.06	694.38	658.99
Total Liabilities & Equity	863.09	839.95	829.41	825.51	844.02	884.79

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	122.48	111.64	111.1	124.35	109.3	192.95
Net Cash (Debt)	-112.08	-91.69	-92.11	-95.85	-25.11	-111.93
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.09	-6.60	-6.63	-6.90	-1.81	-9.76
Filing Date Shares Outstanding	13.83	13.9	13.9	13.9	13.9	13.02
Total Common Shares Outstanding	13.83	13.9	13.9	13.9	13.9	13.02
Working Capital	30.48	43.45	10.06	189.58	113.13	125.2
Book Value Per Share	51.16	50.14	49.05	47.63	49.96	50.60
Tangible Book Value	707.67	680.23	665.18	645.37	677.6	658.87
Tangible Book Value Per Share	51.15	48.94	47.85	46.43	48.75	50.59
Buildings	-	181.93	181.93	181.93	210.58	221.22
Machinery	-	389.14	384.44	376.77	377.95	375.04
Construction In Progress	-	1.51	1.51	0.35	-	38.14

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 12, 2026

Data Sources Report a data error